NuScale Power Stock Falls 70% in 6 Months. Here's Why the Nuclear Energy Company Faces Headwinds.

NuScale Power is benefiting from chatter that U.S. space nuclear reactors could be deployed in orbit by 2028 and on the moon by 2030, with the company’s only NRC-approved SMR design and 700+ patents cited as potential advantages. However, the business remains pre-commercial and unprofitable, and the stock is still down more than 70% over the past six months. The article frames any upside as long-dated and speculative rather than near-term fundamental improvement.

Analysis

This move is less about near-term revenue and more about a regime shift in perceived optionality. The market is starting to price SMR as a policy-levered platform asset rather than a utility-like engineering name, which can drive sharp multiple expansion before any commercial revenue arrives. But that re-rating is fragile: when a story depends on long-dated government procurement, the equity behaves more like a call option than a fundamentals compounder, so financing and execution risk remain the dominant variables.

The second-order winner set is broader than just the company itself. Every incremental credibility boost for small modular reactors can improve sentiment for suppliers of nuclear-grade components, specialized engineering contractors, and uranium-linked equities, but the biggest beneficiary may actually be defense-adjacent primes with integration capability and government contracting scale if space power becomes a strategic procurement category. Conversely, traditional large-reactor developers and capital-intensive utilities could lose narrative share if policymakers favor faster-deployable modular systems over bespoke megaprojects.

The key risk is timing mismatch: the catalyst is policy theater now, but monetization is years away. If milestones slip even 12-18 months, the market may refocus on dilution, operating losses, and the absence of commercial deployments, which would compress the current speculative premium quickly. The stock can keep trending on headlines, but any failure to secure a credible contract or demonstrate a realistic path to build-out by the next budget cycle would likely reverse the move faster than the upside developed.

The contrarian view is that consensus may be underestimating how small the addressable market is in the near term and overestimating how much NRC approval translates into awarded work. Approval is a gating item, not a revenue stream, and in a procurement process this long, first-mover advantage can be offset by political preferences, cost overruns, or a shift toward rival technologies. The best setup is not a full fundamental long; it is a tactical trade on sentiment with strict risk controls and a willingness to fade strength if contract visibility does not improve.

Key Decisions for Investors

• Trade SMR tactically, not structurally: buy on pullbacks only, with a 4-8 week horizon; use a starter long sized as an option-like position given high headline beta and dilution risk.
• Use SMR Jan-2027 call spreads instead of common stock for upside exposure; the payoff is better if policy momentum continues, and downside is capped if procurement slips by 1-2 budget cycles.
• Pair trade: long SMR / short a basket of traditional nuclear or utility names with slower project cycles over 1-3 months; this isolates the narrative re-rating while hedging broad energy-market noise.
• If seeking a cleaner second-order expression, long defense-integrated names with space-systems exposure on any confirmed government procurement milestone; they may capture contract value with less binary technology risk than SMR.
• Set a hard risk trigger: cut or reduce SMR if no credible contract/pricing update emerges within the next 1-2 quarters, since the stock will likely reprice back to balance-sheet and execution concerns.